S-phase delay in human hepatocellular carcinoma cells induced by overexpression of integrin β1

World Journal of Gastroenterology

Volumn 9, Issue 8, 2003, Pages 1689-1696

  Liang, Yu Long ^a   Lei, Ting Wen ^b   Wu, Heng ^a   Su, Jian Min ^a   Wang, Li Ying ^a   Lei, Qun Ying ^a   Zha, Xi Liang ^a  

^a FUDAN UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANTIBIOTIC G 418; BETA1 INTEGRIN; CYCLIN DEPENDENT KINASE INHIBITOR; FOCAL ADHESION KINASE; LIPOFECTAMINE; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PARAMETERS; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOLYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

EID: 0041927809     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i8.1689     Document Type: Article

References (47)

1. Lukashev ME, Werb Z. ECM signalling: Orchestrating cell behaviour and misbehavior. Trends Cell Biol 1998; 8: 437-441
2. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-1032
3. Assoian RK. Anchorage-dependent cell cycle progression. J Cell Biol 1997; 136: 1-4
4. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626
5. Schwartz MA. Integrin signaling revisited. Trends Cell Biol 2001; 11: 466-470
6. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381-395
7. Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512
8. Giancotti FG, Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta 1994; 1198: 47-64
9. Giancotti FG, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990; 60: 849-859
10. Varner JA, Emerson DA, Juliano RL. Integrin α5β1 expression negatively regulates cell growth: Reversal by attachment to fibronectin. Mol Biol Cell 1995; 6: 725-740
11. Zhou GF, Ye F, Cao LH, Zha XL. Overexpression of integrin α5β1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice. Mol Cell Biochem 2000; 207: 49-55
12. Wang D, Sun L, Zborowska E, Willson JK, Gong J, Verraraghavan J, Brattain MG. Control of type II transforming growth factor-β receptor expression by integrin ligation. J Biol Chem 1999; 274: 12840-12847
13. KIP1. Proc Natl Acad Sci USA 10026-10031
14. Su JM, Gui L, Zhou YP, Zha XL. Expression of focal adhesion kinase and α5 and β1 integrins in carcinomas and its clinical significance. World J Gastroenterol 2002; 8: 613-618
15. Munsterberg AE, Lassar AB. Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite. Development 1995; 121: 651-660
16. Takano Y, Kato Y, Van Diest PJ, Masuda M, Mitomi H, Okayasu I. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000; 156: 585-594
17. WAF1 promoter region. Cancer Res 2000;60:3290-3298
18. Kim J, Han I, Kim Y, Kim S, Oh ES. C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase. Biochem J 2001; 360: 239-245
19. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 1989; 264: 380-388
20. Bellis SL, Newman E, Friedman EA. Steps in integrin β1-chain glycosylation mediated by TGFβ1 signaling through Ras. J Cell Physiol 1999; 181: 33-44
21. Yan Z, Chen M, Perucho M, Friedman E. Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin β-chain maturation in colon epithelial cells. J Biol Chem 1997; 272: 30928-30936
22. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol 1998; 10: 220-231
23. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-1163
24. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816
25. Zhang Y, Rishi AK, Dawson MI, Tschang R, Farhana L, Boyanapalli M, Reichert U, Shroot V, Van Buren EC, Fontana JA. S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid. Cancer Res 2000; 60; 2025-2032
26. WAF1/CIP1 expression in human bronchial smooth-muscle cells. Am J Respir Cell Mol Biol 1999;21:395-402
27. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem Sci 2001; 26: 657-664
28. Delcommenne M, Tan C, Gray V, Ruel L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 1998; 95: 11211-11216
29. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 2001; 276: 27462-27469
30. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000; 60: 3689-3695
31. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825
32. 1WAF1/Cip1: More than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43-M56
33. Elledge SJ, Harper JW. The role of protein stability in the cell cycle and cancer. Biochim Biophys Acta 1998; 137: M61-M70
34. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001; 155: 459-470
35. Cheresh DA, Stupack DG. Integrin-mediated death: An explanation of the integrin-knockout phenotype? Nat Med 2002; 8: 193-194
36. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in α5 integrin-deficient mice. Development 1993; 119: 1093-1105
37. Schwartz MA, Ginsberg MH. Networks and crosstalk: Integrin signalling spreads. Nat Cell Biol 2002; 4: E65-E68
38. Blystone SD, Graham IL, Lindberg FP, Brown EJ. Integrin αvβ3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor α5β1. J Cell Biol 1994; 127: 1129-1137
39. Diaz-Gonzalez F, Forsyth J, Steiner B, Ginsberg MH. Trans-dominant inhibition of integrin function. Mol Biol Cell 1996; 7: 1939-1951
40. Blystone SD, Slater SE, Williams MP, Crow MT, Brown EJ. A molecular mechanism of integrin crosstalk: αvβ3 suppression of calcium/calmodulin-dependent protein kinase II regulates α5β1 function. J Cell Biol 1999; 145: 889-897
41. Simon KO, Nutt EM, Abraham DG, Rodan GA, Duong LT. The αvβ3 integrin regulates α5β1-mediated cell migration toward fibronectin. J Biol Chem 1997; 272: 29380-29389
42. Volpes R, Van Den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 1993; 142: 1483-1492
43. Scoazec JY, Fléjou JF, D'Errico A, Fiorentino M, Zamparelli A, Bringuier AF, Feldmann G, Grigioni WF. Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix a cell-cell adhesion molecules. Hepatology 1996; 24: 1128-1136
44. Torumura T, Uneo T, Kin M, Inuzuka S, Sugawara H, Tamaki S, Tsuji R, Sujaku K, Sata M, Tanikawa K. Coordinated expression of integrin α6β1 and laminin in hepatocellular carcinoma. Hum Pathol 1997; 28: 1131-1138
45. Ozaki I, Yamamoto K, Mizuta T, Kajihara S, Fukushima N, Setoguchi Y, Morito F, Sakai T. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 1998; 43: 837-842
46. Masumoto A, Arao S, Otsuki M. Role of β1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology 1999; 29: 68-74
47. Nejjari M, Hafdi Z, Dumortier J, Bringuier AF, Feldmann G, Scoazec JY. α6β1 integrin expression in hepatocarcinoma cells: Regulation and role in cell adhesion and migration. Int J Cancer 1999; 83: 518-525